慢性骨髄性白血病(CML/慢性骨髄性白血病):世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) 26
Subjects Recruited Over a Period of Time 36
Clinical Trials by Sponsor Type 37
Prominent Sponsors 38
Top Companies Participating in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials 39
Prominent Drugs 41
Latest Clinical Trials News on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) 42
Feb 12, 2014: BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia 42
Oct 18, 2013: ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia 43
Sep 04, 2013: ARIAD Reaches 50 Percent Patient Enrollment in Phase 3 EPIC Trial of Iclusig 43
Jun 02, 2013: Ariad Pharma Announces Long-term Durability-of-response Data On Ponatinib From Ongoing Phase I Study 44
Jun 01, 2013: Ariad Pharma Reports Analysis Of Cardiovascular Risk Profile Of Leukemia Patients From Pivotal Phase II PACE Trial Of Iclusig 45
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Bristol-Myers Squibb Company 58
Clinical Trial Overview of Bristol-Myers Squibb Company 58
Pfizer Inc. 62
Clinical Trial Overview of Pfizer Inc. 62
Ariad Pharmaceuticals, Inc. 64
Clinical Trial Overview of Ariad Pharmaceuticals, Inc. 64
Celgene Corporation 65
Clinical Trial Overview of Celgene Corporation 65
Teva Pharmaceutical Industries Limited 66
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 66
Merck & Co., Inc. 67
Clinical Trial Overview of Merck & Co., Inc. 67
F. Hoffmann-La Roche Ltd. 68
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 68
Amgen Inc. 69
Clinical Trial Overview of Amgen Inc. 69
Johnson & Johnson 70
Clinical Trial Overview of Johnson & Johnson 70
Clinical Trial Overview of Top Institutes / Government 71
National Cancer Institute 71
Clinical Trial Overview of National Cancer Institute 71
The University of Texas M. D. Anderson Cancer Center 81
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 81
Fred Hutchinson Cancer Research Center 86
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 86
Memorial Sloan Kettering Cancer Center 91
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 91
National Heart, Lung, and Blood Institute 93
Clinical Trial Overview of National Heart, Lung, and Blood Institute 93
UCLA’s Jonsson Comprehensive Cancer Center 94
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 94
Masonic Cancer Center 95
Clinical Trial Overview of Masonic Cancer Center 95
Gruppo Italiano Malattie EMatologiche dell’Adulto 96
Clinical Trial Overview of Gruppo Italiano Malattie EMatologiche dell’Adulto 96
Australasian Leukaemia and Lymphoma Group 97
Clinical Trial Overview of Australasian Leukaemia and Lymphoma Group 97
Five Key Clinical Profiles 98
Appendix 180
Abbreviations 180
Definitions 180
Research Methodology 181
Secondary Research 181
About GlobalData 182
Contact Us 182
Disclaimer 182
Source 183


【レポート販売概要】

■ タイトル:慢性骨髄性白血病(CML/慢性骨髄性白血病):世界の臨床試験レビュー(2014年上半期)
■ 英文:Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDHC2023CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。